CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte–macrophage colony-stimulating factor-dependent fashion

  1. Silke Gillessen*,
  2. Yuri N. Naumov,
  3. Edward E. S. Nieuwenhuis,
  4. Mark A. Exley§,
  5. Frederick S. Lee,
  6. Nicolas Mach*,
  7. Andrew D. Luster,
  8. Richard S. Blumberg,
  9. Masaru Taniguchi,
  10. Steven P. Balk§,
  11. Jack L. Strominger,**,
  12. Glenn Dranoff*,††, and
  13. S. Brian Wilson,††,‡‡
  1. *Department of Medical Oncology, Dana–Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, MA 02115; Cancer Immunology and AIDS, Dana–Farber Cancer Institute, 44 Binney Street, Boston, MA 02115; Gastrointestinal Division, Brigham and Women's Hospital, Boston, MA 02115; §Cancer Biology Program, Hematology/Oncology Division, Beth Israel Deaconess Medical Center, Boston, MA 02115; Department of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital East, 149 13th Street, Room 8304, Charlestown, MA 02129; Core Research for Evolutional Science and Technology Project and Department of Molecular Immunology, Chiba University, Chiba 260-8670, Japan; **Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138; and ‡‡Diabetes Research Laboratories, Massachusetts General Hospital, Cambridge, MA 02138
  1. Contributed by Jack L. Strominger, May 21, 2003

Abstract

CD1d-restricted T cells contribute to tumor protection, but their precise roles remain unclear. Here we show that tumor cells engineered to secrete granulocyte–macrophage colony-stimulating factor induce the expansion of CD1d-restricted T cells through a mechanism that involves CD1d and macrophage inflammatory protein 2 expression by CD8α, CD11c+ dendritic cells (DCs). The antitumor immunity stimulated by vaccination with irradiated, granulocyte-macrophage colony-stimulating factor-secreting tumor cells was abrogated in CD1d- and Jα281-deficient mice, revealing a critical role for CD1d-restricted T cells in this response. The loss of antitumor immunity was associated with impaired tumorinduced T helper 2 cytokine production, although IFN-γ secretion and cytotoxicity were preserved. DCs from immunized CD1d-deficient mice showed compromised maturation and function. Together, these results delineate a role for CD1d-restricted T cell–DC cross talk in the shaping of antitumor immunity.

Footnotes

  • †† To whom correspondence should be addressed. E-mail: brian_wilson{at}dfci.harvard.edu or glenn_dranoff{at}dfci.harvard.edu.

  • Abbreviations: DC, dendritic cell; GM-CSF, granulocyte–macrophage colony-stimulating factor; FL, Flt3 ligand; FACS, fluorescence-activated cell sorting; TCR, T cell receptor; MIP-2, macrophage inflammatory protein 2; MLR, mixed leukocyte reaction; Th, T helper.

« Previous | Next Article »Table of Contents